The Oncology Institute, Inc. (NASDAQ:TOIIW) Sees Large Decrease in Short Interest

The Oncology Institute, Inc. (NASDAQ:TOIIW) was the recipient of a large decline in short interest in December. As of December 31st, there was short interest totalling 1,700 shares, a decline of 45.2% from the December 15th total of 3,100 shares. Based on an average trading volume of 24,200 shares, the short-interest ratio is currently 0.1 days.

Oncology Institute Stock Up 37.1 %

NASDAQ TOIIW traded up $0.00 on Wednesday, reaching $0.02. The company had a trading volume of 39,347 shares, compared to its average volume of 23,705. Oncology Institute has a 1 year low of $0.01 and a 1 year high of $0.37. The firm has a 50-day moving average of $0.01 and a 200-day moving average of $0.02.

About Oncology Institute

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.